Core Biotech Buys #17: Positive Commentary For Gene Therapy And Our First Swap – Seeking Alpha
|
Core Biotech Buys #17: Positive Commentary For Gene Therapy And Our First Swap
Seeking Alpha FDA Commissioner Scott Gottlieb´s remarks concerning the potential of gene therapy, bode well for stocks participating in that theme. A clinical hold for CRISPR Therapeutics caused some concern but I put it into context. Results from Galapagos´ phase 2 … |
